Synnocare Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $3.19M

  • Investors
  • 3

Synnocare General Information

Description

Developer of small molecule antitumor drugs targeting areas such as malignant tumors, autoimmune diseases, and central nervous system disorders. The company uses artificial intelligence and other technology to develop new drugs, it is a pharmaceutical enterprise empowered by AI (Artificial Intelligence) and Multi-Omics, it focuses on unmet clinical needs and undruggable targets in the field of malignant tumors and immunological diseases, and integrates "AI for Omics" technology into various stages of novel drug research and development, such as target discovery, drug molecular design and clinical trial design, enabling patients to have innovative drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 309, Building B, Number 1369 East Kangqiao Road
  • Pudong New Area
  • Shanghai
  • China
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Room 309, Building B, Number 1369 East Kangqiao Road
  • Pudong New Area
  • Shanghai
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synnocare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 26-Jul-2023 $3.19M Completed Pre-Clinical Trials
1. Early Stage VC 05-Aug-2022 Completed Pre-Clinical Trials
To view Synnocare’s complete valuation and funding history, request access »

Synnocare Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small molecule antitumor drugs targeting areas such as malignant tumors, autoimmune diseases, and central n
Drug Discovery
Shanghai, China
14 As of 2023

Saint-Laurent, Canada
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synnocare Competitors (4)

One of Synnocare’s 4 competitors is Repare Therapeutics, a Formerly VC-backed company based in Saint-Laurent, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Repare Therapeutics Formerly VC-backed Saint-Laurent, Canada
IDEAYA Biosciences Formerly VC-backed South San Francisco, CA
Tango Therapeutics Formerly VC-backed Boston, MA
Abivax Formerly PE-Backed Paris, France
To view Synnocare’s complete competitors history, request access »

Synnocare Patents

Synnocare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026195004-A1 Vav1 degrader, and preparation method therefor and use thereof Pending 21-Mar-2025
WO-2026195005-A1 Vav1 degrader, preparation method therefor and use thereof Pending 21-Mar-2025
WO-2026040999-A1 Dhx9 inhibitor, preparation method therefor, and use thereof Pending 19-Aug-2024
WO-2025232650-A1 Kif18a inhibitor as well as preparation method therefor and use thereof Pending 07-May-2024
EP-4810492-A1 Nmt inhibitor, preparation method therefor, and use thereof Pending 16-Nov-2023 A61P35/00
To view Synnocare’s complete patent history, request access »

Synnocare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synnocare Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Yuanjin Herun Private Equity Fund Management Growth/Expansion Minority
Grains Valley Venture Capital Venture Capital Minority
Nanjing Dynamic balance Investment & Management Growth/Expansion Minority
To view Synnocare’s complete investors history, request access »

Synnocare FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process